Rybrevant Faspro, the new subcutaneous version of amivantamab, was approved for patients with a specific form of lung cancer ...

Even targeted treatments might fall short for certain tumors. March 8, 2012— -- In the realm of targeted cancer treatment, Carla Leslie is a success story. Leslie was diagnosed in September of ...

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

A team at RMIT University in Melbourne say that extremely small metal particles – which they dub ‘nanodots’ – could be ...

While the current approval focuses on the second-line setting, research is already moving into earlier stages of the ...

Researchers at RMIT University in Melbourne have developed minuscule 'nanodots' that show promise for future targeted cancer ...

In the 21st century, technology has transformed every aspect of life – from smartphones connecting the world, to social media ...

The "Targeted Cancer Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's offering. The Targeted Cancer ...

Investing.com -- Hoth Therapeutics Inc (NASDAQ:HOTH) stock rose 5.1% in Friday’s premarket trading after the clinical-stage biopharmaceutical company announced the filing of two U.S. provisional ...

USF medical engineering professors Dr. Richard Heller and Dr. Mark Jaroszeski have spent more than three decades developing a ...

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...